Department of Medicinal Chemistry, University of Kansas, Lawrence, KS 66045, USA.
Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Bioorg Med Chem Lett. 2021 Dec 15;54:128446. doi: 10.1016/j.bmcl.2021.128446. Epub 2021 Nov 9.
A series of analogs based on a prototype aryl aminothiazole γ-secretase modulator (GSM) were synthesized and tested for their effects on the profile of 37-to-42-residue amyloid β-peptides (Aβ), generated through processive proteolysis of precursor protein substrate by γ-secretase. Certain substitutions on the terminal aryl D ring resulted in an altered profile of Aβ production compared to that seen with the parent molecule. Small structural changes led to concentration-dependent increases in Aβ37 and Aβ38 production without parallel decreases in their precursors Aβ40 and Aβ42, respectively. The new compounds therefore apparently also stimulate carboxypeptidase trimming of Aβ peptides ≥ 43 residues, providing novel chemical tools for mechanistic studies of processive proteolysis by γ-secretase.
我们合成了一系列基于芳基氨噻唑 γ-分泌酶调节剂(GSM)原型的类似物,并测试了它们对通过 γ-分泌酶连续蛋白水解产生的 37-42 个残基淀粉样β肽(Aβ)谱的影响。与母体分子相比,末端芳基 D 环上的某些取代导致 Aβ 产生谱发生改变。较小的结构变化导致 Aβ37 和 Aβ38 的产生浓度依赖性增加,而它们的前体 Aβ40 和 Aβ42 分别没有平行减少。因此,这些新化合物显然还刺激了 Aβ 肽≥43 个残基的羧肽酶修剪,为 γ-分泌酶连续蛋白水解的机制研究提供了新的化学工具。